ARCHIVES

Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 39 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

SmithKline Seeks FDA Action Against Homeopathic Smoking-Cessation Gum

March 6, 1998

Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress

June 6, 1980

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

Guest Editorial : Why I Don’t Want to Pay for Your Horoscope: Reflections on FDA Warning to 23 and Me

December 13, 2013

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985

Also: CALGB elects Schilsky to third term as chairman.

July 16, 2004